Quest Diagnostics (DGX)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 2 |
| Ownership rank: | 480 |
| % of all portfolios: | 0.017% |
| Hold Price * : | $212.00 |
| History |
Portfolio Manager |
Activity ▼ |
Share change |
% change to portfolio |
| Q2 2026 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 3.84% |
62,201 |
0.06 |
| ≡ |
Steven Check - Check Capital Management |
Sell 100.00% |
1,300 |
0.02 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
2,756 |
0.01 |
| Q1 2026 |
| ≡ |
First Eagle Investment Management |
Reduce 23.76% |
935 |
0.00 |
| ≡ |
Lee Ainslie - Maverick Capital |
Reduce 88.47% |
21,139 |
0.08 |
| Q3 2025 |
| ≡ |
First Eagle Investment Management |
Reduce 32.68% |
1,862 |
0.00 |
| Q2 2025 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 43.29% |
1,033,882 |
0.99 |
| ≡ |
Sarah Ketterer - Causeway Capital Management |
Sell 100.00% |
120,400 |
0.43 |
| Q1 2025 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 0.37% |
8,958 |
0.01 |
| ≡ |
Steven Check - Check Capital Management |
Reduce 9.41% |
135 |
0.00 |
| ≡ |
Sarah Ketterer - Causeway Capital Management |
Reduce 60.46% |
184,081 |
0.66 |
| Q4 2024 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 0.08% |
1,843 |
0.00 |
| ≡ |
Sarah Ketterer - Causeway Capital Management |
Reduce 10.99% |
37,579 |
0.13 |
| Q3 2024 |
| ≡ |
Steven Check - Check Capital Management |
Reduce 25.38% |
488 |
0.01 |
| ≡ |
Sarah Ketterer - Causeway Capital Management |
Reduce 28.16% |
134,056 |
0.53 |
| Q2 2024 |
| ≡ |
Sarah Ketterer - Causeway Capital Management |
Reduce 4.99% |
25,001 |
0.10 |
| ≡ |
Steven Check - Check Capital Management |
Reduce 98.58% |
133,522 |
1.39 |
| Q1 2024 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 10.70% |
285,401 |
0.21 |
| Q3 2023 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
8,046 |
0.02 |
| Q2 2023 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 0.32% |
4,864 |
0.00 |
| Q1 2023 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 17.27% |
317,071 |
0.30 |
| Q4 2022 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 1.89% |
35,337 |
0.04 |
| ≡ |
First Eagle Investment Management |
Reduce 8.36% |
25 |
0.00 |
| Q3 2022 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 0.99% |
18,655 |
0.02 |
| Q2 2022 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 2.94% |
57,243 |
0.05 |
| Q1 2022 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 2.97% |
59,570 |
0.04 |
| Q4 2021 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 26.84% |
736,328 |
0.59 |
| Q3 2021 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 2.58% |
72,658 |
0.05 |
| Q2 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
2,441 |
0.00 |
| Q1 2021 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 5.12% |
149,852 |
0.08 |
| Q4 2020 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 21.84% |
818,355 |
0.47 |
| Q3 2020 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 3.31% |
128,261 |
0.08 |
| Q1 2020 |
| ≡ |
Christopher Davis - Davis Advisors |
Reduce 0.96% |
37,629 |
0.02 |
| Q4 2016 |
| ≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
37,510 |
0.04 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.